These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8403410)

  • 1. Determination of malonaldehyde in hyperlipemic sera.
    Keddad K; Conti M; Baussan C; Lemonnier A
    Clin Chem; 1993 Oct; 39(10):2202-3. PubMed ID: 8403410
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectively "cross-bridged" hemostatic and blood screening test defects due to glycogenosis type 1 associated extremely hyperlipidemia.
    Balint B; Todorovic-Balint M; Petakov M; Ostojic G; Vucetic D
    Transfus Apher Sci; 2014 Apr; 50(2):314-5. PubMed ID: 24556126
    [No Abstract]   [Full Text] [Related]  

  • 3. Progression of renal damage in glycogen storage disease type I is associated to hyperlipidemia: a multicenter prospective Italian study.
    Melis D; Cozzolino M; Minopoli G; Balivo F; Parini R; Rigoldi M; Paci S; Dionisi-Vici C; Burlina A; Andria G; Parenti G
    J Pediatr; 2015 Apr; 166(4):1079-82. PubMed ID: 25641239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menorrhagia in patients with type I glycogen storage disease.
    Austin SL; El-Gharbawy AH; Kasturi VG; James A; Kishnani PS
    Obstet Gynecol; 2013 Dec; 122(6):1246-54. PubMed ID: 24201678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of Triton WR-1339 induced hyperlipidemia on the effects of benzo(a)pyrene or guaiacol on α- and γ-tocopherol pools and selected markers of pro-/antioxidative balance in rat plasma and erythrocytes.
    Gawlik M; Gawlik MB; Brandys J
    Environ Toxicol Pharmacol; 2012 May; 33(3):386-93. PubMed ID: 22387351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous inhibitors of nitric oxide synthesis and lipid peroxidation in hyperlipidemic rabbits.
    Xiong Y; Li YJ; Yu XJ; Liu GZ; Li NS
    Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):149-52. PubMed ID: 9772666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical therapy of glycogen storage disease.
    Boley SJ; Cohen MI; Gliedman ML
    Pediatrics; 1970 Dec; 46(6):929-33. PubMed ID: 5275633
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of malonaldehyde in oxidized lipids by the Hantzsch fluorometric method.
    Kikugawa K; Kato T; Iwata A
    Anal Biochem; 1988 Nov; 174(2):512-21. PubMed ID: 3239753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased lipogenesis and resistance of lipoproteins to oxidative modification in two patients with glycogen storage disease type 1a.
    Bandsma RH; Rake JP; Visser G; Neese RA; Hellerstein MK; van Duyvenvoorde W; Princen HM; Stellaard F; Smit GP; Kuipers F
    J Pediatr; 2002 Feb; 140(2):256-60. PubMed ID: 11865283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved fluorometric determination of malonaldehyde.
    Conti M; Morand PC; Levillain P; Lemonnier A
    Clin Chem; 1991 Jul; 37(7):1273-5. PubMed ID: 1855301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of jiangzhi zhongyao pian on serum lipid and antioxidation of hyperlipemic patients].
    Liang XC
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1994 Mar; 14(3):139-41, 131. PubMed ID: 7950179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New method for HPLC separation and fluorescence detection of malonaldehyde in normal human plasma.
    Mao J; Zhang H; Luo J; Li L; Zhao R; Zhang R; Liu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 832(1):103-8. PubMed ID: 16439188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III.
    Kalkan Ucar S; Coker M; Sözmen E; Goksen Simsek D; Darcan S
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):383-90. PubMed ID: 19073362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies on different methods of malonaldehyde determination.
    Bird RP; Draper HH
    Methods Enzymol; 1984; 105():299-305. PubMed ID: 6727668
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of fluorescence characteristics of products of peroxidation of membrane phospholipids with those of products derived from reaction of malonaldehyde with glycine as a model of lipofuscin fluorescent substances.
    Shimasaki H; Hirai N; Ueta N
    J Biochem; 1988 Nov; 104(5):761-6. PubMed ID: 3235450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of marine pectin in complex with mineral water on blood antioxidant system in experimental hyperlipidemia].
    Ivanova IL; Ian'kova VI
    Vopr Pitan; 1998; (4):36-8. PubMed ID: 9825472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay of fluorescent lipid peroxidation products.
    Shimasaki H
    Methods Enzymol; 1994; 233():338-46. PubMed ID: 8015468
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of lipid peroxidation and oxidative DNA damage in patients with periodontitis and hyperlipidemia.
    Fentoğlu Ö; Kırzıoğlu FY; Bulut MT; Kumbul Doğuç D; Kulaç E; Önder C; Günhan M
    J Periodontol; 2015 May; 86(5):682-8. PubMed ID: 25612631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple graphene-based pipette tip solid-phase extraction of malondialdehyde from human plasma and its determination by spectrofluorometry.
    Kaykhaii M; Yahyavi H; Hashemi M; Khoshroo MR
    Anal Bioanal Chem; 2016 Jul; 408(18):4907-15. PubMed ID: 27113457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid peroxidation and glutathione system in hyperlipemic rabbits: influence of olive oil administration.
    De La Cruz JP; Quintero L; Villalobos MA; Sánchez de la Cuesta F
    Biochim Biophys Acta; 2000 May; 1485(1):36-44. PubMed ID: 10802247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.